Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.
| Autor: | Gerstein H, Jaeschke R |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 2016 Oct 28; Vol. 126 (10), pp. 803-805. Date of Electronic Publication: 2016 Oct 28. |
| DOI: | 10.20452/pamw.3612 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|